Pet Cancer Therapeutics Market
According to Intent Market Research, the Pet Cancer Therapeutics Market is expected to grow from USD 0.5 Billion in 2024-e at a CAGR of 6.8% to touch USD 0.8 Billion by 2030. The Pet Cancer Therapeutics Market is dominated by key players such as, Zoetis, Boehringer Ingelheim, Elanco Animal Health, Merial (now part of Boehringer Ingelheim), Virbac, and Aratana Therapeutics (Acquired by Elanco).